206 related articles for article (PubMed ID: 9664163)
1. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
Bracho F; Goldman S; Cairo MS
Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
[TBL] [Abstract][Full Text] [Related]
2. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
Lehrnbecher T
Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
[TBL] [Abstract][Full Text] [Related]
3. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
[TBL] [Abstract][Full Text] [Related]
4. Myeloid colony-stimulating factors: use in the newborn.
Sreenan C; Osiovich H
Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
[TBL] [Abstract][Full Text] [Related]
6. Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis.
Goldman S; Ellis R; Dhar V; Cairo MS
Clin Perinatol; 1998 Sep; 25(3):699-710. PubMed ID: 9779342
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
8. Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis.
Parravicini E; van de Ven C; Anderson L; Cairo MS
Transfus Med Rev; 2002 Jan; 16(1):11-24. PubMed ID: 11788926
[TBL] [Abstract][Full Text] [Related]
9. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
Cairo MS; Plunkett JM; Mauss D; Van de ven C
Blood; 1990 Nov; 76(9):1788-94. PubMed ID: 1699622
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
12. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
Castagnola E; Dufour C
Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
[TBL] [Abstract][Full Text] [Related]
13. Lymphokines: enhancement by granulocyte-macrophage and granulocyte colony-stimulating factors of neonatal myeloid kinetics and functional activation of polymorphonuclear leukocytes.
Cairo MS; VandeVen C; Toy C; Mauss D; Sheikh K; Kommareddy S; Modanlou H
Rev Infect Dis; 1990; 12 Suppl 4():S492-7. PubMed ID: 1694596
[TBL] [Abstract][Full Text] [Related]
14. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor.
Cairo MS; van de Ven C; Mauss D; Kommareddy S; Norris K; Sheikh K; Modanlou H
Biol Neonate; 1991; 59(1):13-21. PubMed ID: 1707685
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome.
Papoff P; Christensen RD; Calhoun DA; Juul SE
Biol Neonate; 2001 Aug; 80(2):133-41. PubMed ID: 11509813
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
Ahmad A; Laborada G; Bussel J; Nesin M
Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
[TBL] [Abstract][Full Text] [Related]
19. Effect of granulocyte and granulocyte macrophage colony stimulating factors (G-CSF and GM-CSF) on neonatal neutrophil functions.
Wolach B; Gavrieli R; Pomeranz A
Pediatr Res; 2000 Sep; 48(3):369-73. PubMed ID: 10960505
[TBL] [Abstract][Full Text] [Related]
20. Use of myeloid colony-stimulating factors in neonates with septicemia.
Bernstein HM; Calhoun DA; Christensen RD
Curr Opin Pediatr; 2002 Feb; 14(1):91-4. PubMed ID: 11880741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
